Guidelines on eczema . . . and other stories
BMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2617 (Published 16 November 2023) Cite this as: BMJ 2023;383:p2617
Atopic eczema
Considering the misery it causes, atopic eczema doesn’t get the attention it deserves. But, as a review of guidelines by the American Academy of Dermatology points out, a wide range of effective topical treatments is available. The revised guidelines make strong recommendations for the use of moisturisers, calcineurin inhibitors, corticosteroids, Janus kinase inhibitors, and phosphodiesterase-4 inhibitors. On the other hand, they strongly advise against the use of topical antimicrobials, antiseptics, and antihistamines (J Am Acad Dermatol doi:10.1016/j.jaad.2022.12.029).
Recurrent vascular events after trans ischaemic attack
A registry study of 4000 people who had sustained a transient ischaemic attack or a minor stroke reveals, perhaps not surprisingly, that the subsequent risk of a major vascular event varies …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£33 / $40 / €36 (excludes VAT)
You can download a PDF version for your personal record.